Do you consider ADT intensification with enzalutamide or abiraterone in patients receiving adjuvant radiation with ADT?

I agree with Dr. @Dr. First Last.

One thing to note is ~3% of RADICALS, for example, included pT3b and high grade disease, and almost no patients in the ART vs SRT trials had N+ disease. Was largely GS7 and pT3a population and not the very high risk patients that select surgeons choose to operate on....

The short answer is no. The long answer is that most men even with high risk prostate cancer are presently treated with early salvage RT +/- ADT rather than adjuvant RT +/- ADT given the results of 3 recent phase 3 trials which demonstrated similar results for early salvage radiation vs adjuvant RT,...